Point-of-care heart failure platform: where are we now and where are we going to?

Alexander E Berezin1, Alexander A Berezin2

  • 1Internal Medicine Department, Zaporozhye State Medical University, Zaporozhye, Ukraine.

Insights

Point-of-care (POC) heart failure (HF) platforms offer a more effective approach to HF management than traditional methods. Further research is needed to fully integrate POC HF platforms for improved diagnosis and patient outcomes.

Area of Science:

  • Cardiology
  • Medical Technology
  • Health Informatics

Background:

  • Heart failure (HF) is a primary cause of cardiovascular mortality.
  • Current HF management can be improved with advanced diagnostic and treatment tools.

Purpose of the Study:

  • To review the literature on point-of-care (POC) HF platforms.
  • To assess the role of POC HF platforms in risk stratification, early diagnosis, and treatment of HF.
  • To evaluate the potential of POC HF platforms in improving clinical outcomes.

Main Methods:

  • Literature review of relevant studies on POC HF platforms.
  • Analysis of the components of POC HF platforms, including consultation and diagnostic algorithms.
  • Examination of current guidelines and obstacles to POC implementation.

Main Results:

  • POC HF platforms can aid in risk stratification, early diagnosis, and prognostically beneficial treatment.
  • Partial implementation of POC HF platforms can improve clinical outcomes despite existing obstacles.
  • POC HF platforms are considered more effective than conventional HF management algorithms.

Conclusions:

  • POC HF platforms represent an evolving model for personalized HF management.
  • More research is required to confirm the benefits of POC HF platforms in decision-making and patient care.
  • The integration of POC HF platforms holds promise for enhancing HF patient outcomes.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
42
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
48
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
69
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
88